27486-87-9

Basic information

• Product Name: AC-CYS(TRT)-OH
• Synonyms: ACETYL-S-TRITYL-L-CYSTEINE;AC-CYSTEINE(TRT)-OH;AC-CYS(TRT)-OH;N-ALPHA-ACETYL-S-TRITYL-L-CYSTEINE;NSC 124673;Acetyl-S-trityl-L-cysteine99+%;Ac-L-Cys(Trt)-OH
• CAS NO: 27486-87-9
• Molecular Formula: C₂₄H₂₃NO₃S
• Molecular Weight: 405.51
• Mol File: 27486-87-9.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 619.6±55.0 °C(Predicted)
• Appearance: /Solid
• Density: 1.227±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 3.50±0.10(Predicted)
• CAS DataBase Reference: AC-CYS(TRT)-OH(CAS DataBase Reference)
• NIST Chemistry Reference: AC-CYS(TRT)-OH(27486-87-9)
• EPA Substance Registry System: AC-CYS(TRT)-OH(27486-87-9)

Safety Data

• Hazardous Substances Data: 27486-87-9(Hazardous Substances Data)

Usage

General Description

AC-CYS(TRT)-OH, also known as N-alpha-Acetyl-L-cysteine-O-trityl, is a derivative of L-cysteine, an amino acid. The acetyl group (AC) at one end of the molecule and a hydroxyl group (OH) at the other end increase its solubility and stability. The trityl group (TRT) is a protective group, which prevents unwanted reactions. This chemical is primarily used in peptide synthesis, where protecting groups like TRT are crucial for directing the sequence of amino acids. The modification with AC and TRT allows this compound to participate in chemical reactions without altering the cysteine amino acid itself, thus enabling the creation of specific peptide sequences.

Upstream product

• 76-84-6 triphenylmethyl alcohol 
• 7218-04-4 N-Acetylcysteine 
• 616-91-1 N-acetylcystein 
• 76-83-5 trityl chloride 
• 2799-07-7 S-trityl-L-cysteine 
• 108-24-7 acetic anhydride 

Downstream Products

• 73609-53-7 Ac-Cys(Trt)-ONSu 
• 906666-23-7 2-acetylamino-N-[2-(3,4-dihydroxy-phenyl)-ethyl]-3-tritylsulfanyl-propionamide 
• 311343-09-6 N-(N-ACETYL-S-TRITYL-L-CYSTEINYL)THIAZOLIDINE 
• 3651-67-0 N-methylmorpholine hydrochloride 
• 311343-00-7 N-(N-acetyl-S-trityl-L-cysteinyl)-S-acetylcysteamine 
• 1129670-74-1 2R-(2R-acetylamino-3-tritylsulfanyl-propionylamino)-3-tritylsulfanyl-propionamide 
• 1129670-83-2 2R-[(2R-acetylamino-3-tritylsulfanyl-propionyl)-(methyl)-amino]-3-tert-butyldisulfanyl-propionic acid methyl ester 
• 1370293-38-1 C₂₈H₃₂N₂O₂S 
• 1032314-56-9 C₂₆H₂₇NO₃S 
• 59587-09-6 (R)-2-acetylamino-3-mercapto-propionic acid ethyl ester 
• 1422468-28-7 C₅₂H₅₆N₄O₈S 
• 1294455-59-6 6^I-((N-acetyl-S-trityl-L-cysteinyl)amino)-6^I-deoxy-2^I,3^I-di-O-methyl-hexakis(2^II-VII,3^II-VII,6^II-VII-tri-O-methyl)cyclomaltoheptaose 
• 681144-89-8 N-(N-acetyl-S-trityl-L-cysteinyl)-S-isobutyrylcysteamine 

Relevant articles and documents

Maleimidation of dextran and the application in designing a dextran-camptothecin conjugate

Camptothecin analogs, as commonly used chemotherapy drugs, usually have poor water solubility which has limited their use in the clinic. In order to improve the water-solubility of camptothecin, a new dextran derivative Dex-Mal was synthesized and used in

PROTECTED FUMARIC ACID-BASED METABOLITES FOR THE TREATMENT OF AUTOIMMUNE DISEASES

The present invention provides novel cell-permeable fumarate acyl mercaptoethylamines (FAMs) which have cellular effects including induction of Nrf2 and inhibition of the NFkB pathway. These compounds have utility in medicine including their use in treatment of diseases such as Multiple sclerosis, Non-alcoholic Steatohepatitis, Psoriasis, Inflammatory Arthritis, Inflammatory Bowel Disease, Asthma, Chronic Obstructive Pulmonary Disease, Cancer, Parkinson's Disease, Alzheimer's Disease, Huntington's Disease and Amyotrophic Lateral Sclerosis.

Substrate-initiated synthesis of cell-penetrating poly(disulfide)s

Lessons from surface-initiated polymerization are applied to grow cell-penetrating poly(disulfide)s directly on substrates of free choice. Reductive depolymerization after cellular uptake should then release the native substrates and minimize toxicity. In the presence of thiolated substrates, propagators containing a strained disulfide from asparagusic or, preferably, lipoic acid and a guanidinium cation polymerize into poly(disulfide)s in less than 5 min at room temperature at pH 7. Substrate-initiated polymerization of cationic poly(disulfide)s and their depolymerization with dithiothreitol causes the appearance and disappearance of transport activity in fluorogenic vesicles. The same process is further characterized by gel-permeation chromatography and fluorescence resonance energy transfer.